Kalaris Therapeutics, Inc. (KLRS) › Weighted Average Diluted SharesKalaris Therapeutics, Inc. (KLRS) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 62.78M2022-12-31: 76.65M2023-12-31: 4.52M2024-12-31: 1.34M2025-12-31: 15.27M15.27M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3115.27M+1042.9%2026-03-17From 2025-01-012024-12-311.34M-70.5%2026-03-17From 2024-01-012023-12-314.52M-94.1%2025-03-07From 2023-01-012022-12-3176.65M+22.1%2024-03-15From 2022-01-012021-12-3162.78M—2023-02-15From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)